BRPI0610177A2 - composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo - Google Patents

composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo

Info

Publication number
BRPI0610177A2
BRPI0610177A2 BRPI0610177A BRPI0610177A BRPI0610177A2 BR PI0610177 A2 BRPI0610177 A2 BR PI0610177A2 BR PI0610177 A BRPI0610177 A BR PI0610177A BR PI0610177 A BRPI0610177 A BR PI0610177A BR PI0610177 A2 BRPI0610177 A2 BR PI0610177A2
Authority
BR
Brazil
Prior art keywords
salt
compound
activated receptor
peroxisome proliferator
receptor activator
Prior art date
Application number
BRPI0610177A
Other languages
English (en)
Inventor
Nobutaka Mochiduki
Rie Takahashi
Seiichiro Masui
Shogo Sakuma
Toshitake Hirai
Tomio Yamakawa
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of BRPI0610177A2 publication Critical patent/BRPI0610177A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BRPI0610177A 2005-05-25 2006-05-24 composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo BRPI0610177A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005152949 2005-05-25
PCT/JP2006/310822 WO2006126714A1 (ja) 2005-05-25 2006-05-24 ペルオキシソーム増殖剤活性化受容体の活性化剤

Publications (1)

Publication Number Publication Date
BRPI0610177A2 true BRPI0610177A2 (pt) 2016-11-29

Family

ID=37452127

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0610177A BRPI0610177A2 (pt) 2005-05-25 2006-05-24 composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo

Country Status (12)

Country Link
US (1) US20090203908A1 (pt)
EP (1) EP1897872A1 (pt)
JP (1) JPWO2006126714A1 (pt)
KR (1) KR20080014075A (pt)
CN (1) CN101228144A (pt)
AU (1) AU2006250373A1 (pt)
BR (1) BRPI0610177A2 (pt)
CA (1) CA2609446A1 (pt)
IL (1) IL187530A0 (pt)
NO (1) NO20076632L (pt)
RU (1) RU2007148439A (pt)
WO (1) WO2006126714A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3135672T (pt) 2008-10-10 2020-04-02 Vm Discovery Inc Composições e métodos para o tratamento distúrbios de utilização de álcool, dor e outras doenças
KR20120099378A (ko) * 2009-08-14 2012-09-10 닛뽕 케미파 가부시키가이샤 염증 또는 에너지 대사/생산 관련 질환의 치료 또는 예방을 위한 ｐｐａｒ 델타 리간드의 용도
US11634387B2 (en) 2019-09-26 2023-04-25 Abionyx Pharma Sa Compounds useful for treating liver diseases
WO2022189856A1 (en) * 2021-03-08 2022-09-15 Abionyx Pharma Sa Compounds useful for treating liver diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4790969B2 (ja) * 2000-08-11 2011-10-12 日本ケミファ株式会社 ペルオキシソーム増殖剤応答性受容体δの活性化剤
GB0031103D0 (en) * 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
US7078422B2 (en) * 2001-03-23 2006-07-18 Nippon Chemiphar Co., Ltd. Activator for peroxisome proliferator-activated receptor
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
US7265137B2 (en) * 2001-08-10 2007-09-04 Nippon Chemiphar Co., Ltd. Activator of peroxisome proliferator-activated re-ceptor δ

Also Published As

Publication number Publication date
IL187530A0 (en) 2008-03-20
EP1897872A1 (en) 2008-03-12
US20090203908A1 (en) 2009-08-13
WO2006126714A1 (ja) 2006-11-30
KR20080014075A (ko) 2008-02-13
CN101228144A (zh) 2008-07-23
AU2006250373A1 (en) 2006-11-30
JPWO2006126714A1 (ja) 2008-12-25
RU2007148439A (ru) 2009-06-27
NO20076632L (no) 2008-02-15
CA2609446A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
BRPI0717757A2 (pt) Derivado de haloalquilsulfoanilida ou um sal do mesmo, herbicida, e, método para usar um herbicida
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
BRPI0813863A2 (pt) Derivado de oxopirazina ou um sal agroquimicamente aceitável do mesmo, composto, herbicida, e, método para usar um herbicida
HK1135377A1 (en) Activating agent for peroxisome proliferator activated receptor
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0822033A2 (pt) Composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, kit
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0812877A2 (pt) " compostos de piperazina, uso de um composto de piperazina, composição, e, método para combater vegetação indesejada ".
ES1060473Y (es) Red de proteccion, especialmente para proteccion frente a la caida de piedras o para aseguramiento de taludes.
BRPI0607545A2 (pt) composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
BRPI0614730A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0815957A2 (pt) "composto, composição farmacêutica, métodos e respectivo uso de 1,2,3-triazin-4-onas trissubstituídas e 1,3-pirimidinonas trissubstituídas para a melhora das respostas sinápticas glutamatérgicas"
BRPI0609178A2 (pt) composto ou um sal do mesmo, e, ativador para o receptor ativado do proliferador de peroxissoma delta
BRPI0612396A2 (pt) composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma delta
BRPI0610177A2 (pt) composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo
BRPI0612406A2 (pt) sal de estrôncio, e, uso do mesmo
DE112007002677A5 (de) Tierleine, insbesondere Hundeleine
DE502006000922D1 (de) Richtung
BRPI0612270A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0816800A2 (pt) Composto, composição farmacêutica, e, uso de um composto.
BRPI0821667A2 (pt) Derivado de 15, 16-metileno-17-(1'-propenil)-17,3'-oxidoestra-4-em-3-on a, seu uso e medicamentos contendo o derivado
BRPI0611841A2 (pt) processos para isolar um sal, para preparar um sal, e para a preparação de um composto
ES1059541Y (es) Caja-contenedor perfeccionada para pescado
ITAN20060013U1 (it) Dispositivo di arresto per ante, porte, imposte o simili

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO NO 20070165842/RJ DE 23/11/2007.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: ANULADA A PUBLICACAO 11.6.1 NA RPI 2178 DE 02/10/2012, POR TER SIDO INDEVIDA

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: ANULADA A PUBLICACAO 6.7 NA RPI 2138 DE 27/12/2011, POR TER SIDO INDEVIDA

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]